• Home
  • FAQ
  • Can you develop a dietary supplement, medicine, or cosmetic product based on our concept?

Can you develop a dietary supplement, medicine, or cosmetic product based on our concept?

Yes. We are ready to discuss target properties, technologies, and packaging in detail, as well as assist with product positioning.

Yes. We are ready to discuss target properties, technologies, and packaging in detail, as well as assist with product positioning.

More news:

Встречаемся на SobMaExpo!

Meet us at SobMaExpo!
АО «МираксБиоФарма» подтвердило высочайший уровень системы менеджмента качества

JSC "MiraxBioPharma" has confirmed the highest level of its quality management system.
МираксБиоФарма празднует 20-летний юбилей!

MiraxBioPharma JSC Celebrates its 20th Anniversary
ЭтернаВита — наша инновационная разработка для качественного долголетия

ЭтернаВита — наша инновационная разработка для качественного долголетия

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 721-20-58 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

Используя этот сайт, Вы даете Согласие на сбор и обработку Ваших персональных данных, в том числе с привлечением сторонних сервисов и с применением cookie-файлов и средств веб-аналитики, на условиях, изложенных в Personal Data Processing Policy.